Free Trial

This company has been marked as potentially delisted and may not be actively trading.

ETAO International (ETAO) Competitors

ETAO International logo

ETAO vs. HIMS, TDOC, AUNA, SBC, LFMD, TOI, AIRS, SHLT, CCM, and NMRD

Should you be buying ETAO International stock or one of its competitors? The main competitors of ETAO International include Hims & Hers Health (HIMS), Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Oncology Institute (TOI), AirSculpt Technologies (AIRS), SHL Telemedicine (SHLT), Concord Medical Services (CCM), and Nemaura Medical (NMRD).

ETAO International vs.

ETAO International (NASDAQ:ETAO) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability and institutional ownership.

Hims & Hers Health has higher revenue and earnings than ETAO International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ETAO International$58.89M0.00-$896.68MN/AN/A
Hims & Hers Health$1.48B5.48-$23.55M$0.5467.40

ETAO International has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500.

0.2% of ETAO International shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 20.8% of ETAO International shares are owned by insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Hims & Hers Health had 55 more articles in the media than ETAO International. MarketBeat recorded 55 mentions for Hims & Hers Health and 0 mentions for ETAO International. Hims & Hers Health's average media sentiment score of 0.64 beat ETAO International's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company Overall Sentiment
ETAO International Neutral
Hims & Hers Health Positive

Hims & Hers Health has a net margin of 8.19% compared to ETAO International's net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat ETAO International's return on equity.

Company Net Margins Return on Equity Return on Assets
ETAO InternationalN/A N/A N/A
Hims & Hers Health 8.19%10.97%8.29%

Hims & Hers Health has a consensus target price of $36.92, indicating a potential upside of 1.44%. Given Hims & Hers Health's stronger consensus rating and higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than ETAO International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ETAO International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Hims & Hers Health
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08

Hims & Hers Health received 43 more outperform votes than ETAO International when rated by MarketBeat users.

CompanyUnderperformOutperform
ETAO InternationalN/AN/A
Hims & Hers HealthOutperform Votes
43
35.25%
Underperform Votes
79
64.75%

Summary

Hims & Hers Health beats ETAO International on 12 of the 14 factors compared between the two stocks.

Get ETAO International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETAO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ETAO vs. The Competition

MetricETAO InternationalOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$2,000.00$1.21B$5.53B$7.93B
Dividend YieldN/AN/A5.11%4.22%
P/E RatioN/A20.2722.5118.54
Price / SalesN/A1.24397.62103.30
Price / CashN/A36.0138.1834.62
Price / BookN/A11.206.734.25
Net Income-$896.68M-$52.07M$3.22B$248.18M

ETAO International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ETAO
ETAO International
N/AN/AN/AN/A$2,000.00$58.89M0.003,600
HIMS
Hims & Hers Health
2.3614 of 5 stars
$28.18
+5.5%
$38.25
+35.7%
+191.3%$6.26B$1.48B64.01650Upcoming Earnings
Analyst Forecast
Insider Trade
Options Volume
News Coverage
TDOC
Teladoc Health
3.8064 of 5 stars
$7.23
+2.2%
$10.82
+49.8%
-45.5%$1.26B$2.57B-1.255,100Analyst Forecast
News Coverage
AUNA
Auna
3.5902 of 5 stars
$6.94
+0.4%
$13.50
+94.5%
+1.1%$513.35M$4.39B18.2614,958
SBC
SBC Medical Group
N/A$3.74
+1.6%
N/AN/A$387.51M$205.42M0.00N/A
LFMD
LifeMD
2.4217 of 5 stars
$5.93
+1.9%
$11.00
+85.5%
-36.1%$264.38M$212.45M-9.27230Upcoming Earnings
Analyst Forecast
Insider Trade
Options Volume
News Coverage
Gap Down
TOI
Oncology Institute
0.847 of 5 stars
$3.22
+11.6%
N/A+149.1%$245.57M$393.41M-4.17660Positive News
AIRS
AirSculpt Technologies
1.575 of 5 stars
$1.77
+2.0%
$3.75
+112.5%
-59.0%$103.39M$180.35M-12.61240Upcoming Earnings
SHLT
SHL Telemedicine
N/A$2.05
flat
N/AN/A$33.61M$55.94M0.00583
CCM
Concord Medical Services
0.5912 of 5 stars
$4.73
flat
N/A-12.9%$20.54M$471.70M0.00970Short Interest ↑
Gap Down
Trading Halted
NMRD
Nemaura Medical
N/A$0.00
flat
N/AN/A$8,000.00$3,017.000.0040

Related Companies and Tools


This page (NASDAQ:ETAO) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners